Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

["3Y" problem and principle in gene therapy].

Chun-Song Hu1

  • 1Institute of Cardiovascular Disease, Jiangxi Medical College, Nanchang 330006, China. pinehu@hotmail.com

Yi Chuan = Hereditas
|January 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of COVID-19 Cases and Public Measures in China.

SN comprehensive clinical medicine·2020
Same author

Treatment of chronic heart failure in the 21st century: A new era of biomedical engineering has come.

Chronic diseases and translational medicine·2019
Same author

E-noise: An increasingly relevant health risk.

Journal of integrative medicine·2019
Same author

Scientific papers: Which type would you prefer?

Journal of integrative medicine·2019
Same author

Intervention of RT-ABCDEF for cancer.

Croatian medical journal·2019
Same author

Novel strategies halt cardiovascular, diabetes, and cancer strips.

Chronic diseases and translational medicine·2017

Somatic gene therapy faces challenges in safety, efficacy, and stability. Addressing these "3Y" problems is crucial for advancing gene therapy applications in treating human diseases.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Context:

  • Somatic gene therapy utilizes viral and nonviral vectors for treating human diseases.
  • Current gene therapy applications are limited by gene delivery hazards, low efficiency, and poor intracellular stability.

Purpose:

  • To identify and summarize the key challenges in somatic gene therapy.
  • To propose guiding principles for the safe and effective application of gene therapy.

Summary:

  • The primary obstacles in gene therapy are categorized as "3Y" problems: safety, efficacy, and stability.
  • These "3Y" problems encompass the potential hazards of gene delivery methods, the efficiency of target gene expression, and the intracellular stability of the delivered genetic material.

Impact:

Related Experiment Videos

  • Highlights the critical "3Y" factors (safety, efficacy, stability) that need to be addressed for successful gene therapy.
  • Emphasizes the need for adherence to "3Y" principles to overcome current limitations and advance the field of gene therapy.